Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | PRDM5 |
| Upstream (Parents) |
|---|
| (<<) FZD3 → PRDM5 |
| (<<) PLXNA1 → PRDM5 |
| (<<) PLA2G16 → PRDM5 |
| (<<) RAB11FIP1 → PRDM5 |
| (<<) C15orf5 → PRDM5 |
| (<<) CDK10 → PRDM5 |
| Downstream (Children) |
|---|
| PRDM5 → GPR98 (>>) |
| PRDM5 → COL4A3 (>>) |
| PRDM5 → POU2F3 (>>) |
| PRDM5 → CD207 (>>) |
| PRDM5 → PMCHL1 (>>) |
| PRDM5 → ICMT (>>) |
| PRDM5 → ITGA2B (>>) |
| PRDM5 → FGF16 (>>) |
| PRDM5 → TP53 (>>) |
| PRDM5 → MDM2 (>>) |
| PRDM5 → LOC100131524///RAI2 (>>) |
| PRDM5 → LOC728412///TSPY4///TSPY3///TSPY1 (>>) |
